Alphamab starts phase I clinical trial in Australia
Clinical Research | News | 0 Comment | 11 Oct, 2018
Alphamab Oncology has announced that its proprietary humanized PD-L1 - CTLA-4 bispecific antibody program, the first of ...Read more
Yisheng receives approval for rabies vaccine clinical study
Clinical Research | News | 0 Comment | 10 Oct, 2018
Yisheng Biopharma Co., Ltd., a biopharmaceutical company focusing on research, development, manufacturing, sales and mar...Read more
Eisai receives FDA approval for antiepileptic drug
Clinical Research | News | 0 Comment | 01 Oct, 2018
Eisai Co., Ltd. has announced that its U.S. subsidiary Eisai Inc. received approval from the U.S. Food and Drug Administ...Read more
Atox Bio announces completion of pre-planned safety review
Clinical Research | News | 0 Comment | 25 Sep, 2018
Atox Bio, a clinical stage biotechnology company developing novel therapies for critically ill patients has announced th...Read more
Immutep collaborates with Merck, Pfizer for Efti
Clinical Research | News | 0 Comment | 25 Sep, 2018
Immutep Limited has announced that it has entered into a clinical trial collaboration and supply agreement with Merck KG...Read more
Proxima Clinical Research appoints David Novotny as CSO
Clinical Research | News | 0 Comment | 24 Sep, 2018
David T. Novotny was recently named Chief Strategy Officer (CSO) of Proxima Clinical Research, Inc., a leader in clinica...Read more
Clinical Research | Opinion | By Priyanka Bajpai | 2 Comment | 20 Sep, 2018
Excerpts from the interview In the context of emerging markets in APAC, what are some of the opportunities and challeng...Read more
Innovent presents clinical data of Sintilimab
Clinical Research | News | 0 Comment | 20 Sep, 2018
Innovent Biologics, a world-class China-based biopharmaceutical company that develops and commercializes high quality dr...Read more
CISCRP releases a video to improve diversity in clinical research
Clinical Research | News | 0 Comment | 19 Sep, 2018
The Center for Information and Study on Clinical Research Participation (CISCRP), a Boston-based nonprofit organization,...Read more
Daily intake of Aspirin has little effect on cardiovascular disease, says a study
Clinical Research | News | 0 Comment | 17 Sep, 2018
Three groundbreaking papers published in New England Journal of Medicine, led by a team of Monash University researchers...Read more
Medtronic starts Onyx ONE Clear study in Japan and US
Clinical Research | News | 0 Comment | 14 Sep, 2018
Medtronic has initiated a new clinical study in patients implanted with its Resolute Onyx drug-eluting stent (DES) durin...Read more
Oryzon gets approval for conducting Phase IIa trial of Vafidemstat
Clinical Research | News | 0 Comment | 10 Sep, 2018
Oryzon Genomics, a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseas...Read more
TB Alliance Launches Clinical Trial for New TB drug
Clinical Research | News | 0 Comment | 31 Aug, 2018
TB Alliance, a not-for-profit organization dedicated to finding faster-acting and affordable drug regimens to fight...Read more
NUS researchers uncover a bidirectional regulator in cancer cells
Clinical Research | News | 0 Comment | 20 Aug, 2018
Singapore - An in-depth study on the regulation of adenosine-to-inosine (A-to-I) RNA editing by researchers from the Can...Read more
Tolero Pharmaceuticals collaborates with AbbVie for AML trial
Clinical Research | News | 0 Comment | 20 Aug, 2018
Tolero Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for hematologi...Read more
HSA approves TCR immunotherapy trial for liver cancer
Clinical Research | News | 0 Comment | 20 Aug, 2018
Lion TCR Pte. Ltd., a Singapore-based Biotech company has received approval from Health Sciences Authority (HSA), Singap...Read more
FSD Pharma, SciCann Launch clinical research program in Israel
Clinical Research | News | 0 Comment | 17 Aug, 2018
FSD Pharma announced the launch of a clinical research collaborative program in Israel, via its strategic R&D p...Read more
Kyowa Hakko Kirin announces results of Phase 3 trial of patients with Cutaneous T-cell Lymphoma
Clinical Research | News | 0 Comment | 13 Aug, 2018
Kyowa Hakko Kirin Co., Ltd., (Kyowa Kirin) has announced that results of the global Phase 3 MAVORIC study (Mogamulizumab...Read more